PRINCETON, NJ / ACCESSWIRE / December 17, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (“Sonnet” or the “Company”), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the fiscal year ended September 30th, 2021 and provided a business update.
Pankaj Mohan, Ph.D., Founder
SOUTH SAN FRANCISCO, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of...
(Bloomberg) -- Just hours after being sworn in as governor of Puerto Rico on Saturday, Pedro Pierluisi declared a “fiscal emergency,” requiring government agencies to...
(Reuters) -China will step up fiscal policy support for a strategy to make its economy mainly rely on domestic demand, supply chains and innovation, Finance...
(Reuters) - China will step up fiscal policy support for a strategy to make its economy mainly rely on domestic demand, supply chains and innovation,...
By Davide BarbusciaDUBAI (Reuters) - Oil-rich Gulf nations are relying on a well-worn playbook of spending less and borrowing more to get through the coronavirus...